Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Ortho Clinical Diagnostics Holdings PLC
Revenue
Ortho Clinical Diagnostics Holdings PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
|
Revenue
$2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
See Also
What is Ortho Clinical Diagnostics Holdings PLC's Revenue?
Revenue
2B
USD
Based on the financial report for Jan 2, 2022, Ortho Clinical Diagnostics Holdings PLC's Revenue amounts to 2B USD.
What is Ortho Clinical Diagnostics Holdings PLC's Revenue growth rate?
Revenue CAGR 5Y
4%
Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Ortho Clinical Diagnostics Holdings PLC have been 5% over the past three years , 4% over the past five years .